Podcast Index
Parcourez les podcasts par catégorie, ouvrez les épisodes récents et téléchargez l’audio pour l’écouter hors ligne.
Smart Biotech Scientist | The CMC and Bioprocessing Podcast for Process Development and Manufacturing Leaders
David Brühlmann - CMC Development Leader, Bioprocess Expert, Business Strategist
Retro Radio: Old Time Radio in the Dark
Darren Marlar
NZZ Quantensprung
NZZ
Permaculture P.I.M.P.cast
Permaculture P.I.M.P.cast
Talking Biotech with Dr. Kevin Folta
Kevin Folta
Written in the Ocean
Juan David Escorcia
Defiant Health Radio with Dr. William Davis
William Davis, MD
Artificial Intelligence Masterclass
AI Masterclass
After Skool
After Skool
Quazi Johir
Quazi Johir
ReddX Reddit Reads
ReddX
Off the Trails
Maegan Moaratty and Danielle Falagan
Vince & Weed
Vincent Weed
Lenkin pasji svet
Šola Razumeti psa
NaturallyScott
Scott
iNTO THE FRAY RADIO - Encounters with the Paranormal
Shannon LeGro
Vedanta Cast
Jonas Masetti
'ne Dosis Wissen | Der Medizin-Podcast für Menschen im Gesundheitswesen
Apotheken Umschau Pro & gesundheit-hören
London Weather Daily
Fast Foundations
Recombination Nation
Shane Simonsen
Dark Mysteries — Unsolved Mysteries. Forgotten Secrets. Unanswered Questions.
Darkest Mysteries Online
Women in Wildlife
Eliza Stott
Daily Paper Cast
Jingwen Liang, Gengyu Wang
Bitcoin Takeover Podcast
Vlad Costea
Rachel Lawson's The Magicians Podcast
Rachel Lawson
The Automated Daily - Space News Edition
TrendTeller
Main Engine Cut Off
Anthony Colangelo
PsyberSpace® - we help you understand your world
Dr. Leslie Poston, Research Psychologist: Applied Psychology, Media Psychology, Organizational Psychology
IS PHARMACOLOGY DIFFICULT®️ Podcast
Dr Radhika Vijay
Trending Globally: Politics and Policy
The Watson School
Giants Shoulder
Evan McGloughlin
Chemical Engineering Podcast
Scott Jenkins
The Doctor Who Audio Dramas
Everlasting Films
Blood Podcast
American Society of Hematology
HILAKBOT PINOY HORROR STORIES | The Podcast
RED and The Pod Network
Hausbot Petra Horkého
Petr Horký
The Real Truth About Health Free 17 Day Live Online Conference Podcast
Lloyd Burrell, Keith Block M.D., Jeffrey Smith, Michael Klaper M.D., Ralph Moss, Brenda Davis R.D., Mark Sloan, Gerald Posner, Ian Harris M.D., Neil Barnard M.D., Will Tuttle Ph.D., John McDougall M.D., Pam Popper Ph.D., Gabriel Cousens M.D., Brian Clement Ph.D., Anna Maria Clement Ph.D., Marianne Williamson, Vandana Shiva Ph.D., Aly Cohen M.D., Milton Mills M.D., Theodora Scarato, William Li M.D., David Katz M.D., Stephanie Seneff Ph.D., Julieanna Hever M.S., Dale Bredesen M.D., Hope Bohanec, Kim Williams M.D., Joel Kahn M.D., Michelle Perro M.D., David Wolfe, Melanie Joy Ph.D., Sunil Pai M.D., Baxter Montgomery M.D., Michael Greger M.D., Caldwell Esselstyn M.D., Joel Fuhrman M.D., Colin Campbell Ph.D.
Science
David Brühlmann - CMC Development Leader, Bioprocess Expert, Business Strategist
The cell and gene therapy industry faces massive hurdles—cost, scalability, and the need for highly skilled operators have historically limited the reach of these transformative treatments. advanced therapy medicinal pro...
What if the simple act of opening an incubator could undermine the consistency of your cell therapy manufacturing process? Unlike traditional biologics, the moment cells leave their incubator, subtle shifts in temperatur...
Digital transformation in biotech is no longer just about adopting new tools, it's about building a foundation where automation, data standardization, and AI integration actually lead to real value and long-term success....
Despite cutting-edge equipment and brilliant minds, biotech labs often find half their data trapped in difficult-to-access spreadsheets or isolated in silos, making true digital transformation a major, industry-wide hurd...
Host David Brühlmann returns for a focused solo episode to provide an honest, data-driven perspective on the evolving landscape of host selection for biologics manufacturing. Building on part one, David reviews five alte...
In this solo episode, David Brühlmann explores the evolving landscape of biologic manufacturing platforms beyond CHO (Chinese hamster ovary) cells. Drawing from previous interviews with platform pioneers and rigorous dat...
Funding novel therapeutics isn’t just “harder than ever”—the rules have changed entirely. The wild rush of capital into early-stage biotech during 2020–2021 gave way to a drought, making investor priorities sharper and s...
Strong science alone won’t get your biotech startup funded—investors are sizing up much more than just your molecule.Michael Rome, who leads therapeutics investing at Foresite Capital, brings a rare dual lens as both sci...
What happens between scientific discovery and clinical trials? For too many drug candidates, the answer is “failure”—not because the idea lacked merit, but because the critical handoff between discovery and IND-enabling ...
The gap between a “drug” and a true “product” is where many therapies fail.Milan Tomic, biotech veteran, GMP manufacturing expert, and founder of Albrem, has spent 30 years turning promising science into scalable, execut...
The "data lake" that was supposed to unify bioprocessing intelligence has, in most companies, become something else entirely: a data swamp, where information goes in and insight rarely comes back out. For anyone trying t...
When AI can draft a literature review in minutes, the question bioprocess educators can no longer avoid is this: what does a student actually need to learn?Steffen Kreye has a clear answer. As Professor of Industrial Bio...
Can aging be fundamentally slowed or even reversed—not by science fiction, but by harnessing the unassuming power of super-early stem cells?In Part 1, Yuta Lee, Founder and CEO of Accelerated Bio, walked through the biol...
What if the key to scalable, off-the-shelf cell therapy was hiding in tissue that surgeons discard every day?Yuta Lee, Founder and CEO of Accelerated Bio, has spent two decades building a cell therapy platform on exactly...
Are you still using one-factor-at-a-time experiments for biosimilar development, losing months, missing interactions, and risking costly dead-ends?In this episode, David Brühlmann, host of the Smart Biotech Scientist Pod...
Are you stuck screening endless compounds in biosimilar development and still not hitting your quality targets? Efficient compound screening is one of the toughest bottlenecks in biopharma, with outdated methods slowing ...
When every batch belongs to a single patient, a single centralized facility cannot serve the world. In Part 2, Chantale Bernatchez moves from process development into the broader consequences of that reality: the manufac...
The most underappreciated parameter in cell therapy process development is not your bioreactor, your media, or your activation protocol. It is the patient. Chantale Bernatchez has spent 20 years learning that lesson the ...
Getting an NDA signed shouldn't take weeks. If your CRO needs more than 48 hours to start the paperwork, your project timeline is already moving in the wrong direction.Ron Najafi knows what rigorous analytical work actua...
When drug safety fails, patients and entire markets pay the price. Understanding your CMC isn't just compliance — it's the line between therapeutic promise and product recall.Ron Najafi has lived that reality firsthand. ...
Remplissez le formulaire ci-dessous. Veillez à sélectionner à la fois Pays et Genres.
Envoyez-nous un message ci-dessous. Nous vous répondrons dans les 24 heures.